IRBESARTAN Side Effects

6987413-9 | Interstitial Lung Disease
on Sep 09, 2010 Male patient from FRANCE , 80 years of age, was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Irbesartan dosage: Nov09-mar10;02apr10-02may10(31d). During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), LASIX (View Lasix Review and Lasix Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6985616-0 | Narcolepsy
Patient was taking Irbesartan (View Usage). Patient had the following side effects: narcolepsy on Sep 09, 2010 from NETHERLANDS Additional patient health information: Male patient , 69 years of age, weighting 149.9 lb, was diagnosed with myocardial ischaemia and. Irbesartan dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6938457-4 | Fall, Femoral Neck Fracture, Haemorrhage Intracranial, Operative Haemorrhage
Adverse event was reported on Aug 19, 2010 by a Male patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis and. Location: FRANCE , 71 years of age, weighting 222.7 lb, After Irbesartan was administered, patient had the following side effects: fall (What is fall?), femoral neck fracture, haemorrhage intracranial, operative haemorrhage. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), KREDEX (View Kredex Review and Kredex Label ), BUMEX (View Bumex Review and Bumex Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), KAJOS (View Kajos Review and Kajos Label ), KLEXANE (Klexano Injectios 60 Mg Subcutaneous.) (View Klexane Review and Klexane Label ), MYCOSTATIN (Times 4) (View Mycostatin Review and Mycostatin Label ). Patient was hospitalized.

6938441-0 | Diarrhoea, Facial Bones Fracture, Fall, Femoral Neck Fracture, Haemorrhage Intracranial, Localised Infection, Operative Haemorrhage, Pneumonia, Urinary Tract Infection
on Aug 19, 2010 Male patient from FRANCE , 71 years of age, weighting 222.7 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, facial bones fracture, fall (What is fall?), femoral neck fracture, haemorrhage intracranial, localised infection, operative haemorrhage, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?). Irbesartan dosage: . During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), KREDEX (View Kredex Review and Kredex Label ), BUMEX (View Bumex Review and Bumex Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), KAJOS (View Kajos Review and Kajos Label ), KLEXANE (View Klexane Review and Klexane Label ). Patient was hospitalized.


6933554-1 | Renal Failure
on Jul 12, 2010 Male patient from SPAIN , 62 years of age, was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Irbesartan (View Usage). Patient had the following side effects: renal failure. Irbesartan dosage: . During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), EMCONCOR (Emconcor Cer .5 Mg Tabs) (View Emconcor Review and Emconcor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SINTROM (Sintrom Uno 1 Mg 60 Tabs) (View Sintrom Review and Sintrom Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6883807-0 | Atrial Fibrillation, Blood Pressure Decreased, Overdose, Suicide Attempt, Tachyarrhythmia
Patient was taking Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood pressure decreased, overdose, suicide attempt, tachyarrhythmia on Jul 25, 2010 from GERMANY Additional patient health information: Male patient , 64 years of age, weighting 154.3 lb, . Irbesartan dosage: 1 Df = Maximum Amount Of The Tablet 96.. Patient was hospitalized.

6847854-7 | Agranulocytosis, Septic Shock
Adverse event was reported on Jul 12, 2010 by a Male patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, renal transplant, dyslipidaemia and. Location: FRANCE , 57 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, septic shock. During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), LEXOMIL (1df= 1 Tablet.) (View Lexomil Review and Lexomil Label ), PROGRAF (View Prograf Review and Prograf Label ), FOLDINE (Withdrawn) (View Foldine Review and Foldine Label ).

6831238-1 | Overdose, Suicide Attempt, Tachyarrhythmia
on Jul 05, 2010 Male patient from GERMANY , 64 years of age, was treated with Irbesartan (View Usage). Patient had the following side effects: overdose, suicide attempt, tachyarrhythmia. Irbesartan dosage: 1 Df = Maximum Amount Of The Tablet 96.. Patient was hospitalized.

6816210-X | Bradycardia, Fall, Orthostatic Hypotension
on Jun 28, 2010 Male patient from FRANCE , 87 years of age, was diagnosed with hypertension, type 2 diabetes mellitus, arteritis, cardiac failure and was treated with Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: bradycardia, fall (What is fall?), orthostatic hypotension. Irbesartan dosage: . During the same period patient was treated with LANTUS (Decreased To 1.25mg/day.) (View Lantus Review and Lantus Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), NAFTIDROFURYL (View Naftidrofuryl Review and Naftidrofuryl Label ), MEMANTINE HCL (View Memantine Hcl Review and Memantine Hcl Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PLAVIX (View Plavix Review and Plavix Label ), CORVASAL (View Corvasal Review and Corvasal Label ). Patient was hospitalized.

6751155-5 | Angioedema
Patient was taking Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema on May 24, 2010 from FRANCE Additional patient health information: Female patient , 79 years of age, was diagnosed with type 2 diabetes mellitus and. Irbesartan dosage: . During the same period patient was treated with SITAGLIPTIN PHOSPHATE (View Sitagliptin Phosphate Review and Sitagliptin Phosphate Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), LYSINE ACETYLSALICYLATE (View Lysine Acetylsalicylate Review and Lysine Acetylsalicylate Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6749115-3 |
Adverse event was reported on May 25, 2010 by a Female patient taking Irbesartan (View Usage) (Dosage: ) . Location: BRAZIL , 85 years of age, .

6727501-5 | Cutaneous Vasculitis, Panniculitis
on May 11, 2010 Female patient from UNITED KINGDOM , 74 years of age, weighting 218.3 lb, was diagnosed with hypertension, supraventricular tachycardia and was treated with Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: cutaneous vasculitis, panniculitis. Irbesartan dosage: . During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ).

6720681-7 | Leukocytoclastic Vasculitis
on May 10, 2010 Male patient from FRANCE , 65 years of age, was diagnosed with hypertension, diabetes mellitus, hypercholesterolaemia and was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis. Irbesartan dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CRESTOR (View Crestor Review and Crestor Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), TEMERIT (1 Df= Half Tabs) (View Temerit Review and Temerit Label ). Patient was hospitalized.

6667104-4 | Hospitalisation, Pregnancy
Patient was taking Irbesartan (View Usage). Patient had the following side effects: hospitalisation, pregnancy (What is pregnancy?) on Mar 29, 2010 from BELGIUM Additional patient health information: Female patient , 18 years of age, . Irbesartan dosage: . Patient was hospitalized.

6655276-7 | Mastitis
Adverse event was reported on Mar 22, 2010 by a Male patient taking Irbesartan (View Usage) (Dosage: Duration : 1/2 Year) was diagnosed with hypertension and. Location: GREECE , 55 years of age, After Irbesartan was administered, patient had the following side effects: mastitis.

6651328-6 | Leukocytoclastic Vasculitis
on Mar 22, 2010 Male patient from FRANCE , 65 years of age, was diagnosed with hypertension, diabetes mellitus, hypercholesterolaemia and was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis. Irbesartan dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CRESTOR (View Crestor Review and Crestor Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), TEMERIT (1 Df= Half Tabs) (View Temerit Review and Temerit Label ). Patient was hospitalized.

6647703-6 | Oedema Peripheral, Segmented Hyalinising Vasculitis, Urticaria
on Mar 16, 2010 Female patient from FRANCE , 47 years of age, was treated with Irbesartan (View Usage). Patient had the following side effects: oedema peripheral, segmented hyalinising vasculitis, urticaria. Irbesartan dosage: . During the same period patient was treated with LODOZ (View Lodoz Review and Lodoz Label ), KERLONE (View Kerlone Review and Kerlone Label ). Patient was hospitalized.

6643965-X | Hyperlactacidaemia, Metabolic Acidosis, Renal Failure Acute, Respiratory Distress
Patient was taking Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: hyperlactacidaemia, metabolic acidosis, renal failure acute, respiratory distress on Mar 16, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, . Irbesartan dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TRIATEC (View Triatec Review and Triatec Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), TAHOR (View Tahor Review and Tahor Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6637747-2 | Dysphonia, Myalgia, Tremor
Adverse event was reported on Mar 09, 2010 by a Male patient taking Irbesartan (View Usage) (Dosage: Dose Increased To 150mg/d) was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?), diabetes mellitus, glaucoma (What is glaucoma?), prostatic adenoma, insomnia and. Location: FRANCE , 88 years of age, Patient experienced the following unwanted or unexpected effects: dysphonia, myalgia, tremor. During the same period patient was treated with CORDARONE (1 Df = 2 Scored Tabs Strength = 200mg) (View Cordarone Review and Cordarone Label ), DIGOXIN (1 Df = 1 Tablet Strength = 0.125mg) (View Digoxin Review and Digoxin Label ), GLYBURIDE (1 Df = 3 Scored Tabs Strength = 5mg) (View Glyburide Review and Glyburide Label ), KARDEGIC (1 Sachet Powder) (View Kardegic Review and Kardegic Label ), ALLOPURINOL (Tab) (View Allopurinol Review and Allopurinol Label ), TADENAN (2 Soft Capsules) (View Tadenan Review and Tadenan Label ), TRAVATAN (1df-40 Microgram/ml 1 Eye Drop In Solution) (View Travatan Review and Travatan Label ), HAVLANE (1df-half Scored Tabs) (View Havlane Review and Havlane Label ). Patient was hospitalized.

6634937-X | Aortic Dissection
on Mar 10, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with essential hypertension and was treated with Irbesartan (View Usage). Patient had the following side effects: aortic dissection. Irbesartan dosage: Taken From 02jul09-20aug09 As Conmed Supect: 21aug2009 Taken 100mg. Patient was hospitalized.

6590736-9 | Hepatic Encephalopathy, Hepatic Failure
on Feb 10, 2010 Male patient from FRANCE , 91 years of age, was diagnosed with cardiac failure, benign prostatic hyperplasia, insomnia and was treated with Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: hepatic encephalopathy, hepatic failure. Irbesartan dosage: . During the same period patient was treated with ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), IMOVANE (1 Df= Half Tabs) (View Imovane Review and Imovane Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6523953-4 | Polymyalgia Rheumatica
Patient was taking Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: polymyalgia rheumatica (What is polymyalgia rheumatica?) on Dec 22, 2009 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with essential hypertension, back pain (What is back pain?) and. Irbesartan dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ADOFEED (View Adofeed Review and Adofeed Label ). Patient was hospitalized.

6504297-3 | Gastroenteritis, Renal Failure, Retroperitoneal Haematoma, Therapeutic Agent Toxicity
Adverse event was reported on Nov 20, 2009 by a Male patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis, cardiac disorder, prostatic disorder, fluid retention and. Location: FRANCE , 89 years of age, weighting 183.0 lb, Patient had the following side effects: gastroenteritis (What is gastroenteritis?), renal failure, retroperitoneal haematoma, therapeutic agent toxicity. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6504296-1 | Post Procedural Haematoma, Pyelonephritis
on Nov 20, 2009 Male patient from FRANCE , 67 years of age, weighting 293.2 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: post procedural haematoma, pyelonephritis. Irbesartan dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), PLAVIX (View Plavix Review and Plavix Label ), ENOXAPARIN (View Enoxaparin Review and Enoxaparin Label ). Patient was hospitalized.

6500533-8 | Aortic Dissection
on Dec 10, 2009 Male patient from JAPAN , 69 years of age, was diagnosed with essential hypertension and was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: aortic dissection. Irbesartan dosage: Taken From 02jul09-20aug09 As Conmed Supect: 21aug2009 Taken 100mg. Patient was hospitalized.

6469548-2 | Renal Failure Chronic
Patient was taking Irbesartan (View Usage). Patient had the following side effects: renal failure chronic on Nov 20, 2009 from FRANCE Additional patient health information: Male patient , 77 years of age, weighting 160.9 lb, was diagnosed with hypertension, prophylaxis and. Irbesartan dosage: . During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6467259-0 | Haematoma
Adverse event was reported on Nov 20, 2009 by a Male patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis and. Location: FRANCE , 72 years of age, weighting 238.1 lb, After Irbesartan was administered, patient had the following side effects: haematoma. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

6464924-6 | Haematoma Infection
on Nov 20, 2009 Female patient from FRANCE , 66 years of age, weighting 257.9 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma infection. Irbesartan dosage: . During the same period patient was treated with WARFARIN SODIUM (Temporarily Interrupted From 03-jan-2005 To 19-jan-2005) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6464710-7 | Femur Fracture, Haematoma
on Nov 20, 2009 Male patient from FRANCE , 71 years of age, weighting 238.1 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient had the following side effects: femur fracture, haematoma. Irbesartan dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6464709-0 | Dyspnoea, Hypotension, Renal Failure Acute
Patient was taking Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: dyspnoea, hypotension, renal failure acute on Nov 20, 2009 from FRANCE Additional patient health information: Male patient , 65 years of age, weighting 293.2 lb, was diagnosed with hypertension, prophylaxis and. Irbesartan dosage: Withheld On 23aug2007. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ). Patient was hospitalized.

6464704-1 | Haematoma
Adverse event was reported on Nov 20, 2009 by a Male patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis and. Location: FRANCE , 72 years of age, weighting 238.1 lb, Patient experienced the following unwanted or unexpected effects: haematoma. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

6464702-8 | Gastrointestinal Haemorrhage
on Nov 20, 2009 Male patient from FRANCE , 73 years of age, weighting 169.8 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient had the following side effects: gastrointestinal haemorrhage. Irbesartan dosage: Interrupted For 2 Days. During the same period patient was treated with CLOPIDOGREL BISULFATE (Interrupted For 2 Days) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (Interrupted For 2 Days) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6461967-3 | Facial Bones Fracture, Hypotension, Presyncope
on Nov 20, 2009 Female patient from FRANCE , 83 years of age, weighting 149.9 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: facial bones fracture, hypotension, presyncope. Irbesartan dosage: . During the same period patient was treated with CLOPIDOGREL BISULFATE (Interrupted D/t Event; Restarted On 19-mar-2005) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (Interrupted D/t Event; Restarted On 19-mar-2005) (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6461801-1 | Asthma, Bronchitis Chronic, Dermatitis Allergic, Erysipelas
Patient was taking Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), bronchitis chronic, dermatitis allergic, erysipelas on Nov 20, 2009 from FRANCE Additional patient health information: Female patient , 68 years of age, weighting 198.4 lb, was diagnosed with hypertension, prophylaxis and. Irbesartan dosage: . During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), HYLAK FORTE (View Hylak Forte Review and Hylak Forte Label ), LORATADINE (View Loratadine Review and Loratadine Label ), ROXITHROMYCIN (View Roxithromycin Review and Roxithromycin Label ).

6461726-1 | Inguinal Hernia, Retroperitoneal Haematoma
Adverse event was reported on Nov 20, 2009 by a Male patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis and. Location: FRANCE , 80 years of age, weighting 187.4 lb, Patient had the following side effects: inguinal hernia, retroperitoneal haematoma. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), DOBUTREX (View Dobutrex Review and Dobutrex Label ), EPREX (View Eprex Review and Eprex Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TAZOCIN (View Tazocin Review and Tazocin Label ). Patient was hospitalized and became disabled.

6461717-0 | Hypotonia, Loss Of Consciousness
on Nov 20, 2009 Male patient from FRANCE , 83 years of age, weighting 172.0 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: hypotonia, loss of consciousness. Irbesartan dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), DEXTRAN INJ (View Dextran Inj Review and Dextran Inj Label ), NOOTROPIL (View Nootropil Review and Nootropil Label ). Patient was hospitalized.

6461507-9 | Cholecystitis Acute
on Nov 20, 2009 Female patient from FRANCE , 80 years of age, weighting 194.0 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis acute. Irbesartan dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6461424-4 | Hypotension, Loss Of Consciousness, Sick Sinus Syndrome
Patient was taking Irbesartan (View Usage). Patient had the following side effects: hypotension, loss of consciousness, sick sinus syndrome on Nov 20, 2009 from FRANCE Additional patient health information: Male patient , 78 years of age, weighting 209.4 lb, was diagnosed with hypertension, prophylaxis and. Irbesartan dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), NADROPARIN CALCIUM (View Nadroparin Calcium Review and Nadroparin Calcium Label ). Patient was hospitalized.

6461364-0 | Renal Failure
Adverse event was reported on Nov 20, 2009 by a Female patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis and. Location: FRANCE , 81 years of age, weighting 141.1 lb, After Irbesartan was administered, patient had the following side effects: renal failure. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6461283-X | Epistaxis, Gastrointestinal Haemorrhage
on Nov 20, 2009 Female patient from FRANCE , 72 years of age, weighting 103.6 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, gastrointestinal haemorrhage. Irbesartan dosage: Stopped Due To Event. During the same period patient was treated with CLOPIDOGREL BISULFATE (Stopped Due To Event) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (Stopped Due To Event) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6459117-2 | Gastric Ulcer Haemorrhage
on Nov 20, 2009 Female patient from FRANCE , 72 years of age, weighting 163.1 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient had the following side effects: gastric ulcer haemorrhage. Irbesartan dosage: Restarted On 01-jun-2007. During the same period patient was treated with CLOPIDOGREL BISULFATE (Restarted On 01-jun-2007) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (Restarted On 01-jun-2007.) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6458828-2 | Renal Failure Chronic
Patient was taking Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: renal failure chronic on Nov 20, 2009 from FRANCE Additional patient health information: Male patient , 77 years of age, weighting 160.9 lb, was diagnosed with hypertension, prophylaxis and. Irbesartan dosage: . During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6458805-1 | Cerebral Infarction, Diarrhoea, Facial Bones Fracture, Fall, Femoral Neck Fracture, Haemorrhage Intracranial, Loss Of Consciousness, Operative Haemorrhage, Pneumonia Aspiration
Adverse event was reported on Nov 20, 2009 by a Male patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis and. Location: FRANCE , 71 years of age, weighting 222.7 lb, Patient experienced the following unwanted or unexpected effects: cerebral infarction, diarrhoea, facial bones fracture, fall (What is fall?), femoral neck fracture, haemorrhage intracranial, loss of consciousness, operative haemorrhage, pneumonia aspiration. During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), KREDEX (View Kredex Review and Kredex Label ), BUMEX (View Bumex Review and Bumex Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), KAJOS (View Kajos Review and Kajos Label ), ENOXAPARIN SODIUM (Klexano Injectios 60 Mg Subcutaneous.) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), MYCOSTATIN (Times 4) (View Mycostatin Review and Mycostatin Label ). Patient was hospitalized.

6458802-6 | Diarrhoea, Facial Bones Fracture, Fall, Femoral Neck Fracture, Haemorrhage Intracranial, Localised Infection, Operative Haemorrhage, Pneumonia, Urinary Tract Infection
on Nov 20, 2009 Male patient from FRANCE , 71 years of age, weighting 222.7 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient had the following side effects: diarrhoea, facial bones fracture, fall (What is fall?), femoral neck fracture, haemorrhage intracranial, localised infection, operative haemorrhage, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?). Irbesartan dosage: . During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6456501-8 | Duodenal Ulcer Haemorrhage
on Nov 20, 2009 Male patient from FRANCE , 78 years of age, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: duodenal ulcer haemorrhage. Irbesartan dosage: Stopped; Restarted On 29-apr-2005. During the same period patient was treated with CLOPIDOGREL BISULFATE (Interrupted On 10-apr-2005.) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (Interrupted On 10-apr-2005.) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6456500-6 | Renal Failure, Respiratory Failure, Septic Shock
Patient was taking Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure, respiratory failure, septic shock on Nov 20, 2009 from FRANCE Additional patient health information: Male patient , 71 years of age, weighting 178.6 lb, was diagnosed with hypertension, prophylaxis and. Irbesartan dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), VASOPRESSIN (View Vasopressin Review and Vasopressin Label ), FLUIDEX (View Fluidex Review and Fluidex Label ). Patient was hospitalized.

6456499-2 | Gastrointestinal Haemorrhage, Peptic Ulcer
Adverse event was reported on Nov 20, 2009 by a Female patient taking Irbesartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis and. Location: FRANCE , 69 years of age, weighting 185.2 lb, Patient had the following side effects: gastrointestinal haemorrhage, peptic ulcer (What is peptic ulcer?). During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6454207-2 | Fall
on Nov 20, 2009 Male patient from FRANCE , 87 years of age, weighting 222.7 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). After Irbesartan was administered, patient had the following side effects: fall (What is fall?). Irbesartan dosage: . During the same period patient was treated with CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6454206-0 | Haemorrhage Intracranial, Respiratory Failure
on Nov 20, 2009 Male patient from FRANCE , 77 years of age, weighting 224.9 lb, was diagnosed with hypertension, prophylaxis and was treated with Irbesartan (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial, respiratory failure. Irbesartan dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), DILANTIN (View Dilantin Review and Dilantin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), COMBIVENT (View Combivent Review and Combivent Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized and became disabled.

6445772-X | Anal Haemorrhage, Atrial Fibrillation, Back Pain, Constipation, Dehydration, Dyspepsia, Fear Of Eating, Gastrooesophageal Reflux Disease, Hypertension
Patient was taking Irbesartan (View Usage). Patient had the following side effects: anal haemorrhage, atrial fibrillation (What is atrial fibrillation?), back pain (What is back pain?), constipation (What is constipation?), dehydration, dyspepsia, fear of eating, gastrooesophageal reflux disease, hypertension on Nov 10, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 43 years of age, weighting 360.5 lb, was diagnosed with obesity (What is obesity?), cardiovascular event prophylaxis, cardiac disorder, muscle spasms and. Irbesartan dosage: 150 Mg, Qd. During the same period patient was treated with LISINOPRIL (20 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), SPIRONOLACTONE (50 Mg, Unk) (View Spironolactone Review and Spironolactone Label ), ACOMPLIA (20 Mg, Unk) (View Acomplia Review and Acomplia Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), ATENOLOL (50 Mg, Qd) (View Atenolol Review and Atenolol Label ), ATORVASTATIN (80 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ), CODEINE (120 Mg, Qd) (View Codeine Review and Codeine Label ). Patient was hospitalized.